DiaMedica Therapeutics Inc. (DMAC) Ownership

$4.11

$0.08 (-1.91%)
Last update: 04:00 PM EST
Day's range
$4.01
Day's range
$4.26

DiaMedica Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
COOPERMAN LEON G 05/15/2025 1.63 M $6.16 M   0.00% 3.79%
VANGUARD GROUP INC 05/09/2025 1.35 M $5.12 M   8.80% 3.15%
FIRST MANHATTAN CO. LLC. 05/15/2025 606.44 K $2.30 M   -27.73% 1.42%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 05/13/2025 600.00 K $2.27 M   16.55% 1.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 556.59 K $2.11 M   48.49% 1.30%
BLEICHROEDER LP 05/15/2025 382.32 K $1.45 M   0.00% 0.89%
MILLENNIUM MANAGEMENT LLC 05/15/2025 336.88 K $1.28 M   297.13% 0.79%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 315.74 K $1.20 M   3.27% 0.74%
NORTHERN TRUST CORP 05/13/2025 177.28 K $671.89 K   -1.62% 0.41%
LPL FINANCIAL LLC 05/07/2025 155.30 K $588.59 K   2.17% 0.36%
ROYAL BANK OF CANADA 05/15/2025 155.03 K $588.00 K   46,879.09% 0.36%
GOLDMAN SACHS GROUP INC 05/16/2025 121.80 K $461.63 K   76.66% 0.28%
BLACKROCK, INC. 05/02/2025 106.35 K $403.07 K   -1.42% 0.25%
MORGAN STANLEY 05/15/2025 103.58 K $392.58 K   18.48% 0.24%
STATE STREET CORP 05/15/2025 85.03 K $322.26 K   0.00% 0.20%
RONALD BLUE TRUST, INC. 04/21/2025 69.12 K $261.97 K   0.00% 0.16%
HRT FINANCIAL LP 05/15/2025 56.70 K $214.00 K   100.00% 0.13%
CITADEL ADVISORS LLC 05/15/2025 53.70 K $203.52 K   233.27% 0.13%
CATALYST FINANCIAL PARTNERS LLC 05/02/2025 38.46 K $145.75 K   0.00% 0.09%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 36.93 K $139.96 K   -61.03% 0.09%
ADVISOR GROUP HOLDINGS, INC. 05/12/2025 30.40 K $115.20 K   2,781.23% 0.07%
MERIDIAN WEALTH MANAGEMENT, LLC 05/12/2025 28.82 K $109.21 K   5.88% 0.07%
05/15/2025 27.68 K $104.90 K   100.00% 0.06%
JEFFERIES FINANCIAL GROUP INC. 05/08/2025 26.00 K $98.54 K   0.00% 0.06%
PENSIONMARK FINANCIAL GROUP, LLC 04/29/2025 25.65 K $97.21 K   17.04% 0.06%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 25.27 K $95.77 K   73.31% 0.06%
OMERS ADMINISTRATION CORP 05/14/2025 24.30 K $92.10 K   8.00% 0.06%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 19.34 K $73.30 K   0.00% 0.05%
MARSHALL WACE, LLP 05/15/2025 18.83 K $71.36 K   100.00% 0.04%
BARCLAYS PLC 05/15/2025 18.27 K $69.00 K   -34.11% 0.04%
STONEBRIDGE CAPITAL ADVISORS LLC 05/14/2025 17.50 K $66.33 K   0.00% 0.04%
CITIGROUP INC 05/12/2025 16.77 K $63.54 K   -56.43% 0.04%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 16.48 K $62.47 K   -36.84% 0.04%
CORNERSTONE WEALTH MANAGEMENT, LLC 04/18/2025 16.25 K $61.59 K   100.00% 0.04%
RAYMOND JAMES FINANCIAL INC 05/13/2025 15.67 K $59.38 K   2.62% 0.04%
BANK OF MONTREAL /CAN/ 05/13/2025 15.56 K $58.97 K   0.00% 0.04%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 15.17 K $57.51 K   -9.68% 0.04%
LMR PARTNERS LLP 05/15/2025 15.17 K $57.48 K   100.00% 0.04%
WOLVERINE TRADING, LLC 05/15/2025 14.10 K $53.86 K   100.00% 0.03%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2025 13.34 K $51.00 K   100.00% 0.03%
Y-INTERCEPT (HONG KONG) LTD 05/06/2025 13.34 K $50.54 K   -10.94% 0.03%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 13.25 K $50.23 K   0.02% 0.03%
POINT72 ASIA (SINGAPORE) PTE. LTD. 05/15/2025 12.48 K $47.30 K   100.00% 0.03%
DIAMETRIC CAPITAL, LP 05/14/2025 12.42 K $47.08 K   100.00% 0.03%
SG AMERICAS SECURITIES, LLC 04/15/2025 10.88 K $41.00 K   100.00% 0.03%
MAGNOLIA CAPITAL ADVISORS LLC 05/13/2025 10.00 K $37.90 K   -1.57% 0.02%
MASSMUTUAL TRUST CO FSB/ADV 04/01/2025 4.82 K $18.28 K   0.00% 0.01%
US BANCORP \DE\ 05/08/2025 4.34 K $16.43 K   0.00% 0.01%
CUBIST SYSTEMATIC STRATEGIES, LLC 05/15/2025 3.21 K $12.16 K   100.00% 0.01%
TD WATERHOUSE CANADA INC. 05/09/2025 1.07 K $3.96 K   0.00% 0.00%

DiaMedica Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 60 institutional investors and hedge funds held shares of DiaMedica Therapeutics Inc.. The most heavily invested institutionals were:

COOPERMAN LEON G: 1.63 M

VANGUARD GROUP INC: 1.35 M

FIRST MANHATTAN CO. LLC.: 606,435

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE: 600,000

SUSQUEHANNA INTERNATIONAL GROUP, LLP: 556,593

Bleichroeder LP: 382,317

17.54% of DiaMedica Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 7.67 M shares in the last 24 months. This purchase volume represents approximately $31.52 M in transactions.